RXi Pharmaceuticals Corp. (RXII) Cuts Q2 Loss to 4c/Share
Tweet
Share
E-mailGet Alerts RXII Hot Sheet
Join SI Premium – FREE
RXi Pharmaceuticals Corp. (Nasdaq: RXII) reported Q2 loss of ($0.04), versus a loss of ($0.12) reported in the same period last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
